Maravai Lifesciences Holdings, Inc. (MRVI)
6.935
-0.26
(-3.55%)
USD |
NASDAQ |
Sep 09, 16:00
6.935
0.00 (0.00%)
After-Hours: 18:29
Maravai Lifesciences Holdings Net Income (Quarterly) : -21.63M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.63M |
| March 31, 2026 | -6.377M |
| December 31, 2025 | -63.02M |
| September 30, 2025 | -45.06M |
| June 30, 2025 | -69.84M |
| March 31, 2025 | -52.85M |
| December 31, 2024 | -46.50M |
| September 30, 2024 | -172.46M |
| June 30, 2024 | -18.42M |
| March 31, 2024 | -22.68M |
| December 31, 2023 | -109.98M |
| September 30, 2023 | -15.10M |
| June 30, 2023 | -11.94M |
| March 31, 2023 | -1.348M |
| Date | Value |
|---|---|
| December 31, 2022 | 87.43M |
| September 30, 2022 | 99.65M |
| June 30, 2022 | 156.72M |
| March 31, 2022 | 146.86M |
| December 31, 2021 | 127.11M |
| September 30, 2021 | 132.18M |
| June 30, 2021 | 134.50M |
| March 31, 2021 | 75.46M |
| December 31, 2020 | 14.47M |
| September 30, 2020 | 39.02M |
| June 30, 2020 | 1.442M |
| March 31, 2020 | 23.88M |
| December 31, 2019 | -5.45M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Danaher Corp. | 870.00M |
| Illumina, Inc. | 207.00M |
| Bio-Techne Corp. | 54.64M |
| Waters Corp. | -136.00M |
| West Pharmaceutical Services, Inc. | 154.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 51.44M |
| Total Expenses (Quarterly) | 63.86M |
| EPS Diluted (Quarterly) | -0.0839 |
| Enterprise Value | 1.328B |
| Gross Profit Margin (Quarterly) | 40.14% |
| Profit Margin (Quarterly) | -42.05% |
| Earnings Yield | -7.67% |
| Normalized Earnings Yield | -1.252 |